使用M184V的提米丁模拟突变显著降低HIV-1亚型C逆转录酶对伊斯拉特拉维尔的表型敏感性
Hyeonah Byun1, Maria Antonia Papathanasopoulos1, Kim Steegen2,3
1HIV Pathogenesis Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.
Viruses
|January 8, 2025
概括
伊斯拉特拉维尔对常见的HIV-1亚型C核酸逆转录酶抑制剂耐药性突变显示出有效性. 然而,涉及M184V与蒂米丁模拟突变的组合可能会降低敏感性,影响治疗策略.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊斯拉特拉维尔 (ISL) 是一种具有独特作用机制的新型核逆转录酶转位抑制剂 (NRTtI).
- 关于ISL耐药性的数据有限,特别是非B型HIV-1亚型.
- 了解抗性模式对于优化ISL的临床实用性至关重要.
研究的目的:
- 评估艾滋病毒-1亚型C对伊斯拉特拉维尔 (ISL) 的常见核子中的反转录酶抑制剂 (NRTI) 耐药突变的表型耐药性.
- 评估单个和组合的NRTI耐药性突变对HIV-1亚型C的ISL易感性的影响.
主要方法:
- 从HIV-1基因型药物耐药性测试数据库中选择了流行NRTI耐药突变.
- 将这些突变引入HIV-1亚型C类伪病毒.
- 通过表型耐药性测试评估ISL易感性.
主要成果:
- 单个NRTI耐药性突变显示出低水平或没有对ISL的耐药性.
- 结合M184V与蒂米丁模拟突变 (TAMs),特别是TAM-2的组合,降低了ISL易感性.
- M184V与K65R的组合并没有显著影响ISL易感性.
结论:
- 对于那些未能接受诺福维尔二松醇烟酸 (TDF) / 拉米丁 (3TC) 或TDF/埃姆特里丁 (FTC) 治疗方案的患者来说,ISL可能是有效的.
- 由于特定的耐药性突变组合,ISL可能对3TC或FTC疗法失败的齐多武丁 (AZT) 患者效果较差.
- 需要进行进一步的研究,以充分阐明不同HIV-1亚型的ISL耐药性概况.
关键词:
艾滋病病毒 艾滋病病毒 艾滋病病毒这就是为什么NRTI是NRTI.抗逆转录病毒治疗 (ART)抗病毒药物 抗病毒药物药物耐药性 耐药性 药物耐药性伊斯拉特拉维尔 (ISL) 是一种现象型的表型C亚型的C亚型是C亚型的更多相关视频
18:10Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
Published on: June 16, 2011
29.5K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
350
相关概念视频
Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Retrovirus Life Cycles
45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
